Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Wehkamp

Showing results (31-40 of 122) with videos related to

Pageof 13
Sort By:
Therapeutic Advances in Gastroenterology|May 16, 2018
Practical guidance for the management of iron deficiency in patients with inflammatory bowel diseaseDorothea Niepel, Thomas Klag, Nisar P Malek, et al.
Journal of Leukocyte Biology|December 25, 2004
Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's diseaseJan Wehkamp, Michael Schmid, Klaus Fellermann, et al.
World Journal of Gastroenterology|September 24, 2008
Crohn's disease--defect in innate defenceMichael Gersemann, Jan Wehkamp, Klaus Fellermann, et al.
World Journal of Gastroenterology|February 28, 2014
Intestinal barrier in inflammatory bowel diseaseLena Antoni, Sabine Nuding, Jan Wehkamp, et al.
International Journal of Medical Microbiology : IJMM|October 24, 2009
Innate antimicrobial host defense in small intestinal Crohn's diseaseMaureen J Koslowski, Julia Beisner, Eduard F Stange, et al.
European Journal of Gastroenterology & Hepatology|July 4, 2003
Crohn's disease: a defensin deficiency syndrome?Klaus Fellermann, Jan Wehkamp, Klaus R Herrlinger, et al.
International Journal of Medical Microbiology : IJMM|July 4, 2012
Construction of recombinant E. coli Nissle 1917 (EcN) strains for the expression and secretion of defensinsEan-jeong Seo, Stephanie Weibel, Jan Wehkamp, et al.
Deutsches Arzteblatt International|July 15, 2016
In ReplyJan Wehkamp, Martin Götz, Klaus Herrlinger, et al.
Deutsches Arzteblatt International|February 23, 2016
Inflammatory Bowel DiseaseJan Wehkamp, Martin Götz, Klaus Herrlinger, et al.
Intestinal Research|May 28, 2019
Ustekinumab is effective in biological refractory Crohn's disease patients-regardless of approval study selection criteriaSadik Saman, Martin Goetz, Judith Wendler, et al.
Pageof 13

Showing results (31-40 of 122) with videos related to

Sort By:
Pageof 13
Therapeutic Advances in Gastroenterology|May 16, 2018
Practical guidance for the management of iron deficiency in patients with inflammatory bowel diseaseDorothea Niepel, Thomas Klag, Nisar P Malek, et al.
Journal of Leukocyte Biology|December 25, 2004
Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's diseaseJan Wehkamp, Michael Schmid, Klaus Fellermann, et al.
World Journal of Gastroenterology|September 24, 2008
Crohn's disease--defect in innate defenceMichael Gersemann, Jan Wehkamp, Klaus Fellermann, et al.
World Journal of Gastroenterology|February 28, 2014
Intestinal barrier in inflammatory bowel diseaseLena Antoni, Sabine Nuding, Jan Wehkamp, et al.
International Journal of Medical Microbiology : IJMM|October 24, 2009
Innate antimicrobial host defense in small intestinal Crohn's diseaseMaureen J Koslowski, Julia Beisner, Eduard F Stange, et al.
European Journal of Gastroenterology & Hepatology|July 4, 2003
Crohn's disease: a defensin deficiency syndrome?Klaus Fellermann, Jan Wehkamp, Klaus R Herrlinger, et al.
International Journal of Medical Microbiology : IJMM|July 4, 2012
Construction of recombinant E. coli Nissle 1917 (EcN) strains for the expression and secretion of defensinsEan-jeong Seo, Stephanie Weibel, Jan Wehkamp, et al.
Deutsches Arzteblatt International|July 15, 2016
In ReplyJan Wehkamp, Martin Götz, Klaus Herrlinger, et al.
Deutsches Arzteblatt International|February 23, 2016
Inflammatory Bowel DiseaseJan Wehkamp, Martin Götz, Klaus Herrlinger, et al.
Intestinal Research|May 28, 2019
Ustekinumab is effective in biological refractory Crohn's disease patients-regardless of approval study selection criteriaSadik Saman, Martin Goetz, Judith Wendler, et al.
Pageof 13